HS 3505-10-20-00 – Pregelatinized starch; Soluble starch (amylogen)

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

Dextrins and other modified starches (for example, pregelatinized or esterified starches); glues based on starches, or on dextrins or other modified starches. › Dextrins and other modified starches › Pregelatinized starch; Soluble starch (amylogen)

MFN duty rate

6.5 %

GST

5%

Unit of measure

KGM

Pregelatinized starch; Soluble starch (amylogen)

Estimate duty & taxes · Get classification help

Preferential tariff rates

• Jordan (JT): Free
• CPTPP – United Kingdom (CPUKT): Free
• Panama (PAT): Free
• MXT/CUSMA (Mexico): Free
• Costa Rica (CRT): Free
• CETA: Free
• Korea: Free
• Peru: Free
• UK: Free
• LDCT: Free
• Israel (CIAT): Free
• UST/CUSMA (US): Free
• Colombia: Free
• CPTPP: Free
• Chile: Free
• Commonwealth Caribbean Countries Tariff (CCCT): Free
• GPT: 3%
• Ukraine: Free
• Honduras (HNT): Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Pregelatinized starch; Soluble starch (amylogen) (HS 3505-10-20-00)?

The T2026-2 MFN rate for tariff item 3505.10.20 is 6.5%. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 3505-10-20-00 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 3505-10-20-00?

Jordan (JT): Free; CPTPP – United Kingdom (CPUKT): Free; Panama (PAT): Free; MXT/CUSMA (Mexico): Free; Costa Rica (CRT): Free; CETA: Free; Korea: Free; Peru: Free; UK: Free; LDCT: Free; Israel (CIAT): Free; UST/CUSMA (US): Free; Colombia: Free; CPTPP: Free; Chile: Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; GPT: 3%; Ukraine: Free; Honduras (HNT): Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.